Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.12.2016 | geriatrics: at crossroads of medicine | Sonderheft 7/2016

Wiener klinische Wochenschrift 7/2016

P4 medicine and osteoporosis: a systematic review

Zeitschrift:
Wiener klinische Wochenschrift > Sonderheft 7/2016
Autoren:
Klemen Kodrič, Klemen Čamernik, Darko Černe, Radko Komadina, EuSpLM Prof. Dr. Janja Marc

Summary

Background

Osteoporosis is the most frequent bone metabolic disease. In order to improve early detection, prediction, prevention, diagnosis, and treatment of the disease, a new model of P4 medicine (personalized, predictive, preventive, and participatory medicine) could be applied. The aim of this work was to systematically review the publications of four different types of “omics” studies related to osteoporosis, in order to discover novel predictive, preventive, diagnostic, and therapeutic targets for better management of the geriatric population.

Methods

To systematically search the PubMed database, we created specific groups of criteria for four different types of “omics” information on osteoporosis: genomic, transcriptomic, proteomic, and metabolomic. We then analyzed the intersections between them in order to find correlations and common pathways or molecules with important roles in osteoporosis, and with a potential application in disease prediction, prevention, diagnosis, or treatment.

Results

Altogether, 180 publications of “omics” studies in the field of osteoporosis were found and reviewed at first selection. After introducing the inclusion and exclusion criteria (the secondary selection), 46 papers were included in the systematic review.

Conclusions

The intersection of reviewed papers identified five genes (ESR1, IBSP, CTNNB1, SOX4, and IDUA) and processes like the Wnt pathway, JAK/STAT signaling, and ERK/MAPK, which should be further validated for their predictive, diagnostic, or other clinical value in osteoporosis. Such molecular insights will enable us to fit osteoporosis into the P4 strategy and could increase the effectiveness of disease prediction and prevention, with a decrease in morbidity in the geriatric population.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Sonderheft 7/2016

Wiener klinische Wochenschrift 7/2016 Zur Ausgabe

geriatrics: at crossroads of medicine

Frailty and sarcopenia in elderly